Department of Plastic and Reconstructive Surgery, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Department of Plastic and Reconstructive Surgery, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
J Plast Reconstr Aesthet Surg. 2016 Aug;69(8):1080-6. doi: 10.1016/j.bjps.2016.01.018. Epub 2016 Feb 11.
Local relapse after breast-conserving therapy including whole breast irradiation is typically treated by salvage mastectomy. Immediate reconstruction by pedicled transfer of a latissimus dorsi flap in combination with implantation of a definitive prosthesis or temporary tissue expander following skin sparing salvage mastectomy has been shown to be feasible. However, it has never been shown to be justifiable.
The aim of the study was to compare the outcome of this procedure to the widely accepted secondary breast reconstruction by combined latissimus dorsi flap and implant after mastectomy and adjuvant radiotherapy.
The surgical outcome of 93 immediate latissimus dorsi and implant reconstructions after skin-sparing salvage mastectomy performed from 2007 to 2011 after radiotherapy was compared to that of 83 secondary reconstructions with the latissimus dorsi and an implant. The follow-up duration was 3.5 years in both groups. Complications were categorized as minor (conservative treatment sufficed) or major (flap loss, mammary skin loss, implant loss, seroma or haematoma indicating repeat surgery).
The salvage group scored significantly less on half of the patient-related and procedure-related risk factors. Nevertheless, we observed 27% of short-term major surgical complications and an ultimate success rate of 94% in the salvage group compared to those observed in our series of secondary reconstruction in post-radiation women (27% and 93%, respectively).
Skin-sparing salvage mastectomy combined with immediate reconstruction by transfer of a latissimus dorsi flap with an implant is a justifiable reconstructive option for women with a recurrence after irradiation as part of breast-conserving therapy.
保乳治疗(包括全乳房照射)后局部复发通常采用挽救性乳房切除术治疗。已证实,在保乳术后行保留皮肤的挽救性乳房切除术,同期行带蒂背阔肌皮瓣游离移植,并植入永久性假体或临时组织扩张器,即刻重建乳房是可行的,但尚未证明其合理性。
本研究旨在比较该方法与广泛接受的保乳术后联合背阔肌皮瓣和假体辅助放疗的二次乳房重建的结果。
比较了 2007 年至 2011 年放疗后行保留皮肤的挽救性乳房切除术同期行即刻背阔肌皮瓣和假体重建的 93 例患者,与 83 例接受保乳术后联合背阔肌皮瓣和假体的二次重建患者的手术结果。两组随访时间均为 3.5 年。并发症分为轻度(保守治疗即可)或重度(皮瓣坏死、乳房皮肤坏死、假体丢失、血清肿或血肿需再次手术)。
挽救组在一半的患者相关和手术相关危险因素方面评分显著较低。然而,我们在挽救组中观察到 27%的短期严重手术并发症,最终成功率为 94%,而在我们的放疗后女性二次重建系列中观察到的为 27%和 93%。
对于接受放疗的保乳治疗后复发的女性,保留皮肤的挽救性乳房切除术联合即刻带蒂背阔肌皮瓣和假体重建是一种合理的重建选择。